Psoriasis
News
Off-Label Uses for Biologics Growing
News
Ustekinumab 4-Year Data Show No Increased Cardiovascular Risk
Major Finding: The observed combined rate of MI, stroke, and cardiovascular death in psoriasis patients on ustekinumab for at least 4 years was 0....
News
Rare Lymphoma Reports Continue in Young Patients on TNF Blockers
News
Anti-TNFs in Pregnancy Study Advises Continued Caution
Major Finding: Among women who took anti–tumor necrosis factor drugs at the time of conception, 24% of pregnancies ended in spontaneous abortion...
News
Interrupting Biologics Possible, Not Ideal
News
TRACTISS to Study Rituximab Effects in Sjögren's Syndrome
Major Finding: TRACTISS is expected to start patient recruitment in July 2011 and will investigate the use of rituximab vs. placebo for the...
News
Treating Psoriasis During Pregnancy Presents Unique Challenges
News
Platelet C4d Predicts Cardiovascular Events, Mortality in Lupus
News
Juvenile Dermatomyositis Is Easily Missed Diagnosis
Article
Interaction Between Adalimumab With Concurrent Pregabalin and Duloxetine Administration in a Psoriasis Patient With Diabetic Peripheral Neuropathy [letter]
No abstract available.